Nivolumab-induced IgA nephropathy in a patient with advanced gastric cancer: A case report

INTRODUCTION: Immune checkpoint inhibitors including nivolumab, an antibody against programmed death-1, have been increasingly introduced in various cancer treatment regimens, and are reported to be associated with immune-related adverse events. Nivolumab-induced renal injury is generally caused by...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanabe, Katsuyuki, Kanzaki, Hiromitsu, Wada, Takahira, Nakashima, Yuri, Sugiyama, Hitoshi, Okada, Hiroyuki, Wada, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249867/
https://www.ncbi.nlm.nih.gov/pubmed/32481351
http://dx.doi.org/10.1097/MD.0000000000020464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249867/
https://www.ncbi.nlm.nih.gov/pubmed/32481351
http://dx.doi.org/10.1097/MD.0000000000020464

Ejemplares similares